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Abstract
Background: Maternal vitamin D status has been associated with both gestational diabetes mellitus (GDM) and fetal
growth restriction, however, the evidence is inconsistent. In Finland, maternal vitamin D status has improved considerably
due to national health policies. Our objective was to compare maternal 25-hydroxy vitamin D concentrations [25(OH)D]
between mothers with and without GDM, and to investigate if an association existed between maternal vitamin D
concentration and infant birth size.
Methods: This cross-sectional study included 723 mother-child pairs. Mothers were of Caucasian origin, and infants were
born at term with normal birth weight. GDM diagnosis and birth size were obtained from medical records. Maternal
25(OH)D was determined on average at 11 weeks of gestation in pregnancy and in umbilical cord blood (UCB) at birth.
Results: GDM was observed in 81 of the 723 women (11%). Of the study population, 97% were vitamin D sufficient
[25(OH)D≥ 50 nmol/L]. There was no difference in pregnancy 25(OH)D concentration between GDM and non-GDM
mothers (82 vs 82 nmol/L, P = 0.99). Regression analysis confirmed no association between oral glucose tolerance test
results and maternal 25(OH)D (P > 0.53). Regarding the birth size, mothers with optimal pregnancy 25(OH)D (≥ 80 nmol/L)
had heavier newborns than those with suboptimal pregnancy 25(OH)D (P = 0.010). However, mothers with optimal UCB
25(OH)D had newborns with smaller head circumference than those with suboptimal 25(OH)D (P= 0.003), which was
further confirmed as a linear association (P = 0.024).
Conclusions: Maternal vitamin D concentration was similar in mothers with and without GDM in a mostly vitamin D
sufficient population. Associations between maternal vitamin D status and birth size were inconsistent. A sufficient
maternal vitamin D status, specified as 25(OH)D above 50 nmol/L, may be a threshold above which the physiological
requirements of pregnancy are achieved.
Trial registration: The project protocol is registered in ClinicalTrials.gov in November 8, 2012 (NCT01723852).
Keywords: Maternal vitamin D status, Newborn vitamin D status, 25-hydroxy vitamin D concentration, Gestational
diabetes mellitus, Birth size, Birth weight, Birth length, Head circumference, Ponderal index
Background
Vitamin D deficiency, defined as a circulating 25-hydroxy
vitamin D (25(OH)D) concentration below 50 nmol/L,
has been common among Finnish pregnant women [1].
However, due to recent changes in national health
policies, intake of vitamin D has increased resulting in
decreasing rates of vitamin D deficiency [2–5]. Vitamin D
deficiency has been associated with gestational diabetes
mellitus (GDM) [6], but the evidence is inconsistent [7, 8].
Of all pregnancies, 1–14% are affected by GDM [9], and
globally GDM prevalence has been increasing in line with
increasing obesity [10]. GDM is the most common preg-
nancy complication in Europe [11]. In Finland, the preva-
lence of GDM has increased from 6% in 2008 to 11% in
2014 [12]. GDM increases the risk of adverse pregnancy
and neonatal outcomes, and the risk of obesity, metabolic
syndrome, diabetes, and cardiovascular disease in later life
both of the mother and the child [13].
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Fetal growth may have later health implications also
within the normal-birth-weight range [14]. Poor mater-
nal vitamin D status has been related to fetal growth
restriction [15] but it is unknown whether maternal vita-
min D status associates with birth size in infants with
normal birth weight.
Many of the findings regarding the relationship between
vitamin D deficiency and GDM are based on case-control
studies, which may include a potential selection bias.
Case-control studies often focus on high-risk groups, for
example women who are overweight and sedentary, which
are independent risk factors for vitamin D deficiency as
well (for example [16]).
The objectives of the present study were to compare
25(OH)D concentration at two consecutive time points
between mothers with and without GDM, and to investi-
gate associations between maternal factors and infant’s
birth size, and the potential role of 25(OH)D concentra-
tion therein.
The study is part of the longitudinal Vitamin D Inter-
vention in Infants (VIDI) study.
Methods
Recruitment and study participants
At Kätilöopisto Maternity Hospital, Helsinki, Finland,
987 families were recruited into the VIDI study between
January 2013 and June 2014, after delivery during the
mother’s hospital stay. According to the inclusion criteria,
the mothers were of Caucasian origin without regular
medication and with singleton pregnancy. Exclusion cri-
teria for the newborns were: nasal continuous positive air-
way pressure treatment >one day, intravenous glucose
infusion, seizures, duration of phototherapy >three days
and need for nasogastric tube >one day. The infants were
born between 37 + 0 and 42 + 0 weeks of gestation, and
newborn’s birth weight was appropriate for gestational age
(SD-score [SDS] between −2.0 and +2.0). Of the recruited
eligible families, 29% (987/3408) agreed to participate in
the VIDI study. For the present cross-sectional study, we
included mothers who had a record from a community
prenatal clinic or baseline questionnaire and both two ma-
ternal 25(OH)D measurements. Two infants with a con-
genital disease (Down syndrome and Rieger syndrome)
were excluded. Thus, the total number of subjects was
723. Of the infants, 367 were girls and 356 boys. Number
of subjects in each analysis is reported in Tables.
25(OH)D analyses
Maternal pregnancy serum samples for 25(OH)D measure-
ments were collected at community prenatal clinics at ges-
tational weeks 7 to 25 between June 2012 and November
2013 as part of the mothers’ normal follow-up [hereafter re-
ferred to as pregnancy 25(OH)D]. At birth, umbilical cord
blood (UCB) for 25(OH)D measurement was obtained at
gestational weeks 37 to 42 between January 2013 and
May 2014 [hereafter referred to as UCB 25(OH)D]. Both
pregnancy serum and UCB plasma 25(OH)D were ana-
lysed simultaneously using the IDS-iSYS fully automated
immunoassay system with chemiluminescence detection
(Immunodiagnostic Systems Ltd., Bolton, UK). Detailed
information on 25(OH)D analysis has been previously
reported [5]. The quality and accuracy of the serum
25(OH)D analysis is validated on an ongoing basis by par-
ticipation in the vitamin D External Quality Assessment
Scheme (DEQAS, Charing Cross Hospital, London, UK).
Both 25(OH)D concentrations were corrected by
applying a linear regression equation (Oct 2014 value
(nmol/L) = [(early 2014 value) – 8.2] / 0.99) provided by
the manufacturer because of methodological changes in
the IDS-iSYS system between 2014 and 2016 (see
Additional file 1). We re-analysed a subsample of 77
samples and verified the correction (adjusted R2 = 0.922,
SEE = 9.2 nmol/l).
We employed UCB 25(OH)D to reflect both the ma-
ternal vitamin D status at the end of pregnancy and the
newborn’s vitamin D status at birth [1]. We defined vita-
min D deficiency as 25(OH)D < 50 nmol/L, and vitamin
D sufficiency as 25(OH)D ≥ 50 nmol/L, since a concen-
tration of ≥50 nmol/L is considered sufficient for bone
health [17]. Suboptimal vitamin D status was defined as
25(OH)D < 80 nmol/L, and optimal vitamin D status as
25(OH)D ≥ 80 nmol/L, as has been suggested based on
calcium absorption studies [18].
Maternal and newborn data
Maternal data were obtained from a self-administered
baseline questionnaire, filled in after delivery, and from
medical records. Maternal height (cm) and weight (kg) be-
fore pregnancy and parity were collected primarily from
the prenatal maternity card or, if missing, from our baseline
questionnaire. Gestation was determined by first trimester
ultrasound examination. Maternal age was determined at
delivery. Parity was categorised into nullipara, secundipara
and multipara (>two deliveries). Prepregnancy body mass
index (BMI) (kg/m2) was categorised into underweight
(<18.5), normal weight (18.5–24.9), overweight (25.0–29.9)
and obese (>30.0).
Prepregnancy weight and weight recorded in prenatal
clinics were utilised to calculate gestational weight gain
(GWG) (kg). We recorded GWG at first measurement,
at approximately the 12th, 20th and 30th gestational
weeks, and at last measurement. GWG was adjusted for
consecutive gestational week. Concerning the analysis of
total GWG, absolute values were used, and women who
had their final weight recorded more than three weeks
before the delivery were omitted (n = 7). Total GWG
was categorised into inadequate, adequate and excessive
based on national recommendations by prepregnancy
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BMI: recommended GWG for underweight mothers was
12.5–18.0 kg, for normal weight 11.5–16.0 kg, for over-
weight 7.0–11.5 kg, and for obese 5.0–9.0 kg [19].
Education level was graded from one (=comprehensive
school/lower secondary education) to six (university
degree/first or second stage of tertiary education).
Education was re-categorised into ‘lower’ and ‘higher’
education (lower = lower or upper secondary or post-
secondary non-tertiary education, higher = first or
second stage of tertiary education), due to a low number
of subjects in other education categories. Prepregnancy
smoking status was assessed as number of cigarettes per
day. Maternal use of supplements, specific brand names,
dosing, and date of commencement were recorded. We
calculated the average daily intake of vitamin D from
supplementation during the last two months of
pregnancy.
Birth size, including birth weight (kg), length (cm), and
head circumference (cm), was measured by midwives ac-
cording to standard procedure. These data and the dur-
ation of pregnancy were retrospectively collected from
birth records. Birth size measures were transformed into
SDS by using Finnish sex-specific normative data for
fetal growth [20]. Ponderal index was calculated (birth
weight (kg) / birth length (m)3) and standardised into
sex-specific z-score.
Assessment of GDM
The diagnosis of GDM was based on a two-hour 75 g
oral glucose tolerance test (OGTT). According to the
national guidelines, GDM was diagnosed if the OGTT
results exceeded cut-offs for one or more values: fasting
plasma glucose ≥5.3 mmol/l, 1-h ≥ 10.0 mmol/l and 2-
h ≥ 8.6 mmol/l [19]. An OGTT was performed at gesta-
tional weeks 10 to 40 between October 2012 and March
2014, and the results were collected from prenatal ma-
ternity cards or the hospital laboratory database. In gen-
eral, screening for GDM depends on a presence of risk
factors according to national recommendations [19] and
based on these, OGTT was performed on 490 (54.5%) of
the participating mothers. None of the pregnant women
in our study received insulin therapy nor other regular
medication, but mothers with GDM obtained dietary
counselling at community prenatal clinics [19].
Statistical analysis
The normality of the variables was visually inspected.
Outliers (n = 18) of 25(OH)D concentrations were iden-
tified with Normal probability plot of residuals, Leverage
and Cook’s Distance diagnostic tests, and omitted from
the analyses. Season with four categories affected mater-
nal 25(OH)D concentrations. Thus, season at pregnancy
blood sampling and at birth was coded using dummy
variables (with autumn as a reference) in ANCOVA and
used as a covariate.
The data included partially missing information. Imput-
ation of missing values for education (n = 12) and parity
(n = 2) were conducted using the median value in sub-
groups by GDM status. Missing data on prepregnancy
smoking as number of cigarettes daily were imputed as a
median value (= zero) by GDM status according to smok-
ing status (n = 22). Imputation of missing values for GWG
at 12 gestational weeks was conducted using a mean value
of two consecutive measurements (n = 12). Missing values
of other variables were not imputed. Maternal characteris-
tics in Table 1 are described only as un-imputed values.
Independent sample t-tests, Mann-Whitney U-tests, re-
peated measures ANOVA or the Pearson Chi-Square test,
when appropriate, were applied to compare maternal char-
acteristics between GDM and non-GDM mothers. The
difference in 25(OH)D between GDM and non-GDM
mothers was investigated with ANCOVA adjusted for
season, maternal age, education and prepregnancy BMI.
Association between pregnancy 25(OH)D and OGTT
results/birth weight, and between UCB 25(OH)D and
head circumference at birth were tested with univariate
linear regression. Prevalence of vitamin D deficiency
in non-GDM and GDM mothers were tested with
Fisher’s Exact test.
Newborn birth size was investigated in categories of ma-
ternal prepregnancy BMI (underweight, normal weight,
overweight, obese), GWG (inadequate, adequate, excessive),
prepregnancy smoking status (yes, no), maternal education
(higher, lower), parity (nullipara, secundipara, multipara),
GDM status (yes, no), vitamin D status (suboptimal,
optimal) in pregnancy and in UCB, with ANCOVA with
Bonferroni correction when applicable, and adjusted for
maternal height. Changing covariates appearing in the
ANCOVA models were: prepregnancy BMI, GWG at
last measurement, smoking, education, parity, GDM and
25(OH)D concentrations. Using both 25(OH)D concen-
trations as covariates in the GWG analysis induced a
multicollinearity problem based on Cook’s Distance and
Levene’s test, but excluding these covariates from the
model did not change the results.
Results are shown as means or adjusted means with SD
or SEM. The means and medians were similar in both
vitamin D concentrations. Associations were considered
significant at P < 0.05. All statistical analyses were con-
ducted using the IBM SPSS program for Windows, ver-
sion 22 (IBM, Chicago, IL, USA).
Results
In the study population 97% were vitamin D sufficient
[25(OH)D > 50 nmol/L] in both mothers and newborns,
while optimal vitamin D status [25(OH)D above 80 nmol/L]
was seen in 52% of the mothers and 45% of the newborns.
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Majority (95%) of the mothers took vitamin D supplements
during pregnancy, most of them were highly educated (75%
had at least a bachelor level education), and 73% had normal
weight before pregnancy.
Vitamin D status and GDM
In our cohort GDM was present in 81 of the 723 women
(11%). The comparison of maternal characteristics of
GDM and non-GDM mothers is summarised in Table 1.
Pregnancy 25(OH)D concentration was measured on
average at 11 weeks of gestation, and GDM was diag-
nosed on average at 26 weeks of gestation in both GDM
and non-GDM mothers. Mothers with GDM were older
(P = 0.018), heavier and had higher prepregnancy BMI
(P for both <0.001), and their educational level was at
borderline of significance (P = 0.051) lower compared
with mothers without GDM. No differences between
the groups were observed in several other characteris-
tics, including GWG, duration of gestation, and sup-
plemental vitamin D intake.
We investigated whether pregnancy 25(OH)D concen-
tration differed between mothers with (n = 81) and with-
out GDM (n = 639) (Fig. 1) in a crude model and in a
model adjusted for season, maternal age, education and
prepregnancy BMI. Adjusted analysis confirmed no dif-
ference in mean ± SEM pregnancy 25(OH)D concentra-
tion between GDM and non-GDM mothers (81.7 ± 2.3
vs 81.7 ± 0.8 nmol/L, P = 0.99). Similarly in UCB, the ad-
justed analysis showed no difference in 25(OH)D concen-
trations in infants born to women with and without GDM
(79.1 ± 2.3 vs 80.1 ± 0.8 nmol/L, P = 0.69) (Fig. 1). These re-
sults remained when only those who had undergone
OGTT were included: pregnancy and UCB 25(OH)D con-
centrations were similar in GDM (n = 80) and non-GDM
mothers (n = 323) (P = 0.94 and P = 0.43, respectively).
We further tested for possible associations between
pregnancy 25(OH)D concentration and OGTT results
with a univariate regression model. We observed no associ-
ation between pregnancy 25(OH)D and fasting plasma
glucose (B -0.00; 95% CI -0.00, 0.00; P = 0.54), 1-h glucose
(B 0.00; 95% CI -0.01, 0.01; P = 0.53) or 2-h glucose
(B -0.00; 95% CI -0.01, 0.01; P = 0.54).
The prevalence of vitamin D deficiency [25(OH)D <
50 nmol/L] during pregnancy was similar between mothers
with or without GDM [4.9% (4/81) vs 3.3% (21/642),
P = 0.51]. However, more GDM mothers were vitamin D
deficient at the delivery compared with non-GDM mothers
[7.4% (6/81) vs 2.8% (18/642) (P = 0.042)]. However, of
Table 1 Maternal characteristics in GDM and non-GDM mothers. P-values refer to differences between the groups
Maternal characteristics n Non-GDM n GDM p value
Age at delivery (y) 642 31.4 ± 4.3 81 32.7 ± 4.5 0.018
Level of educationa 632 5.0 ± 1.3 79 4.7 ± 1.4 0.051
Parity 640 1.5 ± 0.7 81 1.5 ± 0.7 0.275
Prepregnancy smoking, number of cigarettes daily 625 1.2 ± 3.7 76 2.0 ± 4.6 0.064
Alcohol consumption before pregnancy, portion/wk. 625 1.9 ± 2.0 78 2.3 ± 3.5 0.755
Prepregnancy height (cm) 642 166.3 ± 6.0 81 165.9 ± 5.4 0.398
Prepregnancy weight (kg) 631 63.5 ± 10.2 81 72.1 ± 13.5 <0.001
Prepregnancy BMI (kg/m2) 639 23.0 ± 3.5 81 26.2 ± 4.8 <0.001
Duration of gestation at OGTT (wk) 323 26.3 ± 4.3 80 25.9 ± 5.9 0.774
Duration of gestation at pregnancy blood sampling (wk) 642 11.3 ± 1.9 81 11.2 ± 2.2 0.089
Duration of gestation at delivery (wk) 642 40.2 ± 1.1 81 40.1 ± 1.1 0.410
Pregnancy 25(OH)D (nmol/L) 642 81.9 ± 19.5 81 80.0 ± 21.2 0.417
UCB 25(OH)D (nmol/L) 642 80.1 ± 20.0 81 78.4 ± 18.8 0.448
Supplemental vitamin D intake during pregnancy (μg/d) 621 15.5 ± 16.6 76 13.5 ± 10.8 0.162
Cumulative gestational weight gain atb (kg) 0.093
first measurement 580 1.7 ± 0.5 74 1.6 ± 0.5
12th gestational week 580 3.8 ± 1.0 74 3.6 ± 1.1
20th gestational week 580 6.3 ± 0.8 74 6.2 ± 0.8
30th gestational week 580 9.7 ± 0.5 74 9.7 ± 0.4
last measurement 580 13.8 ± 0.4 74 13.7 ± 0.3
GDM gestational diabetes mellitus, 25(OH)D 25-hydroxy vitamin D, UCB umbilical cord blood
Values are means ± SD
aScale from 1 = lower secondary education to 6 = first or second stage of tertiary education
bValues are adjusted for duration of gestation
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these six deficient GDM-mothers five (83%) were smokers,
and correspondingly in non-GDM mothers four out of
eighteen were smokers (24%) (P = 0.018).
Maternal 25(OH)D and newborn birth size
The effect of maternal factors on birth size in fully adjusted
models is presented in Table 2 and Fig. 2. Neither preg-
nancy 25(OH)D nor UCB 25(OH)D concentrations were
related to birth length or ponderal index. As compared to
mothers with suboptimal pregnancy 25(OH)D, mothers
with optimal pregnancy 25(OH)D had heavier newborns
(P= 0.010), but this positive association was not verified in
linear regression (B 0.00; 95% CI -0.00, 0.01; P= 0.16).
Newborn head circumference was larger in those with
suboptimal UBC 25(OH)D compared with mothers with op-
timal UCB 25(OH)D (P= 0.003). Further, linear regression
confirmed the inverse association between UCB 25(OH)D
and head circumference (B -1.74; 95% CI -3.25, −0.23;
P = 0.024). These results did not change after adjusting
for mode of delivery (vaginal, vacuum assisted or caesar-
ean section). Prepregnancy BMI, GWG, and parity had in-
dependent effects on birth size (Table 2 and Fig. 2).
Discussion
The primary focus of this work was to determine whether
25(OH)D concentration differs between mothers with and
without GDM, and whether vitamin D status affects
birth size in normal-birth-weight infants. GDM was
diagnosed in 11% of mothers in our cohort. Almost all
mother-child pairs (97%) were vitamin D sufficient
[25(OH)D ≥ 50 nmol/L], and about half of the mother-
child pairs had optimal vitamin D status [25(OH)D ≥
80 nmol/L]. Maternal 25(OH)D concentrations were
similar in GDM and non-GDM mothers. Interestingly,
pregnancy vitamin D status associated positively with
birth weight, but an inverse association was observed
between newborn vitamin D status and head circum-
ference at birth.
Lu et al. (2016) concluded in their meta-analysis
that maternal vitamin D insufficiency (< 50 nmol/L
or <75 nmol/L) was associated with greater risk of GDM
[6]. However, they suggested that this applied only in
developed countries and when no adjustments for con-
founders were made [6]. In our study, maternal vitamin
D concentrations were similar in non-GDM and GDM
Fig. 1 Maternal vitamin D status and gestational diabetes mellitus. Adjusted mean ± SEM values of pregnancy 25(OH)D (a) and UCB 25(OH)D
concentration (nmol/L) (b) in GDM and non-GDM mothers. Adjustments are for season, maternal age, education and prepregnancy BMI. Maternal
25(OH)D concentrations were similar between non-GDM and GDM mothers. Abbreviations: 25(OH)D, 25-hydroxy vitamin D; UCB, umbilical cord
blood; GDM, gestational diabetes mellitus
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mothers, and there was no linear association between vita-
min D concentrations and OGTT results. However, we
observed that vitamin D deficiency at delivery was more
prevalent in mothers with GDM compared with non-
GDM mothers, but this was not marked during preg-
nancy. This finding was possibly confounded by smoking,
which was more prevalent in the deficient GDM mothers
compared with deficient non-GDM mothers. Nevertheless
due to small number of deficient mothers we could not in-
vestigate this reliably. In accordance with other studies,
our results imply that in a vitamin D sufficient population,
the association between 25(OH)D and GDM may not
exist [8, 21, 22]. Similarly, Josefson et al. (2016) stated that
maternal fasting glucose or GDM status was not associ-
ated with pregnancy 25(OH)D, which in their study was
on average 93 nmol/L [23].
GDM is a multifactorial disease involving various risk
factors, for example lifestyle factors, obesity, rapid
weight gain and predisposing genetic factors. Further-
more, some of these factors are related to or co-exist
with poor vitamin D status [24, 25], which further in-
creases the challenge when dissecting independent ef-
fect. It is possible that in previous studies where no
adjustment for confounding factors was performed, the
association between 25(OH)D and GDM reflects shared
factors such as an unhealthy lifestyle or adiposity [26].
Table 2 Independent effect of maternal factors on birth sizea
Birth weight (SDS) Birth length (SDS) Head circumference (SDS)b Ponderal index (z-score)c
Maternal factors n p value p value p value p value
Prepregnancy BMI 0.020 0.201 0.364 0.719
Underweight 19 −0.49 ± 0.17 −0.36 ± 0.19 −0.34 ± 0.22 −0.12 ± 0.23
Normal weight 494 −0.30 ± 0.03 −0.23 ± 0.04 −0.14 ± 0.04 −0.01 ± 0.05
Overweight 117 −0.13 ± 0.07 −0.12 ± 0.08 −0.04 ± 0.09 0.08 ± 0.09
Obese 44 −0.05 ± 0.12 −0.01 ± 0.13 0.03 ± 0.14 0.08 ± 0.16
Gestational weight gain <0.001 0.006 0.186 0.505
Inadequate 164 −0.43 ± 0.06 −0.37 ± 0.07 −0.23 ± 0.07 −0.05 ± 0.08
Adequate 261 −0.28 ± 0.05 −0.20 ± 0.05 −0.11 ± 0.06 −0.02 ± 0.06
Excessive 242 −0.12 ± 0.05 −0.09 ± 0.06 −0.05 ± 0.06 0.07 ± 0.07
Prepregnancy smoking 0.021 0.227 0.093 0.173
Yes 101 −0.43 ± 0.08 −0.30 ± 0.09 −0.27 ± 0.10 −0.13 ± 0.11
No 573 −0.23 ± 0.03 −0.18 ± 0.04 −0.09 ± 0.04 0.03 ± 0.04
Maternal education 0.972 0.670 0.721 0.634
Higher 513 −0.26 ± 0.03 −0.19 ± 0.04 −0.11 ± 0.04 −0.00 ± 0.05
Lower 161 −0.26 ± 0.06 −0.23 ± 0.07 −0.14 ± 0.08 0.04 ± 0.08
Parity <0.001 <0.001 0.007 0.027
Nullipara 431 −0.40 ± 0.04 −0.32 ± 0.04 −0.20 ± 0.05 −0.05 ± 0.05
Secundipara 185 −0.03 ± 0.05 −0.05 ± 0.06 −0.03 ± 0.07 0.18 ± 0.07
Multipara 58 0.04 ± 0.10 0.22 ± 0.11 0.17 ± 0.12 −0.07 ± 0.13
Gestational diabetes mellitus 0.063 0.559 0.351 0.075
Yes 76 −0.10 ± 0.09 −0.15 ± 0.10 −0.02 ± 0.11 0.21 ± 0.12
No 598 −0.28 ± 0.03 −0.21 ± 0.03 −0.13 ± 0.04 −0.02 ± 0.04
Pregnancy 25(OH)D concentration 0.010 0.095 0.398 0.236
Suboptimal (<80 nmol/L) 333 −0.34 ± 0.04 −0.26 ± 0.05 −0.15 ± 0.05 −0.04 ± 0.06
Optimal (≥80 nmol/L) 341 −0.19 ± 0.04 −0.15 ± 0.05 −0.09 ± 0.05 0.05 ± 0.06
UCB 25(OH)D concentration 0.149 0.486 0.003 0.234
Suboptimal (<80 nmol/L) 369 −0.22 ± 0.04 −0.18 ± 0.04 −0.02 ± 0.05 0.05 ± 0.05
Optimal (≥80 nmol/L) 305 −0.31 ± 0.04 −0.23 ± 0.05 −0.24 ± 0.05 −0.05 ± 0.06
25(OH)D 25-hydroxy vitamin D, UCB umbilical cord blood
Values are adjusted mean ± SEM. p value is in bold when statistically significant
a Adjusted for maternal height and other listed maternal factors as changing covariates
b Two values are missing from analyses
c Adjusted for gestational age
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Yet, contrary to many studies, associations between high
25(OH)D and GDM have been reported [27, 28]. Al-
though a biological mechanism between low vitamin D
status and diabetes is plausible [29], only a few interven-
tions have been conducted, and these have not proved an
effect of vitamin D supplementation on risk of GDM [30].
Maternal vitamin D status associated with birth size:
pregnancy 25(OH)D showed a positive association to-
wards birth weight, but UCB 25(OH)D an inverse asso-
ciation with head circumference, while only the inverse
association with head circumference was verified with
linear model. Harvey et al. (2014) concluded that modest
evidence exist for a positive relation between maternal vita-
min D status and birth weight [31]. Some earlier studies
have shown that severe maternal vitamin D deficiency asso-
ciates with smaller head circumference at birth [32, 33], yet
some have not [34, 35]. In agreement with our findings,
others have discovered that mothers with higher vitamin D
concentration have infants with smaller head circumference
at birth [36, 37]. However, the clinical relevance, if any, of
the inverse relationship between maternal vitamin D status
and head circumference at birth remains unexplained. It is
unknown whether this reflects differences in brain size or
in skull bones’ structure, and needs to be explored in future
studies. The mean difference in head circumference was
0.22 SD units between the groups with optimal and sub-
optimal UCB 25OHD. A possible explanation for this
might be a U-shaped association between maternal vitamin
D concentration and fetal outcomes in a population with
sufficient vitamin D status. We have previously suggested
the U-shaped association between 25(OH)D concentration
and inflammatory biomarkers in cord blood [5].
We have collected a homogenous cohort of Caucasian
mothers from the capital region of Finland representing
mothers without regular medication and their newborns
who were born at term with normal birth weight. In
many previous studies, participants had various ethnic
backgrounds which could affect both vitamin D status
and their risk of GDM [7, 38]. A strength of the present
study lies in the recruitment of subjects, which took
place in a single hospital, enabled standardised data col-
lection and covered all seasons. However, a multi-centre
study might have resulted in a wider variety of socio-
economic backgrounds.
A challenge in previous studies on vitamin D status
and GDM has been the lack of relevant adjustments, for
example adjustments for BMI and smoking status [6]. In
the present study, we have systematically investigated
Fig. 2 Maternal factors and birth size. Adjusted mean ± SEM values of birth weight, length, head circumference SD-scores and ponderal index
z-score between (a) maternal prepregnancy BMI groups of underweight, normal weight, overweight and obese; (b) mothers’ inadequate GWG,
adequate GWG and excessive GWG; (c) GDM and non-GDM mothers; (d) suboptimal and optimal pregnancy 25(OH)D; and (e) suboptimal and
optimal UCB 25(OH)D. Statistical significance is denoted by *P < 0.05, **P < 0.01 and ***P < 0.001. Abbreviations: GWG, gestational weight gain;
GDM, gestational diabetes mellitus; 25(OH)D, 25-hydroxy vitamin D; suboptimal, UCB, umbilical cord blood; 25(OH)D < 80 nmol/L;
optimal 25(OH)D≥ 80 nmol/L
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confounders between groups, and adjusted for those
when applicable. The threshold for defining vitamin D
deficiency and the diagnostic criteria for GDM vary be-
tween studies, which might affect the results and com-
plicate the comparison of studies. A further limitation is
that the OGTT was not performed on all mothers, and a
slight possibility exists that the actual prevalence of
GDM might be underestimated. Yet, our main results
were repeated in a subgroup analysis of only those
women to whom an OGTT was performed. In addition,
the prevalence of GDM was in accordance with the na-
tional statistics [12]. However, in a cross-sectional set-
ting causal relationships cannot be determined.
Conclusion
In summary, maternal vitamin D concentration was similar
in mothers with and without GDM in a vitamin D sufficient
population. Furthermore, we found an inverse association
between UCB 25(OH)D and infant head circumference.
The clinical relevance of this finding remains unsolved and
needs to be considered in future studies. Sufficient maternal
vitamin D status, specified as 25(OH)D above 50 nmol/L,
seems a threshold value, above which the physiological
requirements of pregnancy are achieved. Our findings sug-
gest that an adequate maternal vitamin status have been
achieved in Finland. However, randomised controlled
trials are required in specific risk groups of vitamin D
deficiency to clarify if vitamin D supplementation affects
the risk of GDM.
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